Ignite Creation Date:
2024-05-05 @ 11:16 PM
Last Modification Date:
2024-10-26 @ 10:31 AM
Study NCT ID:
NCT01295827
Status:
COMPLETED
Last Update Posted:
2019-12-13
First Post:
2011-02-10
Brief Title:
Study of Pembrolizumab MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma Melanoma or Non-small Cell Lung Carcinoma P07990MK-3475-001KEYNOTE-001
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Organization Data
Organization:
Merck Sharp Dohme LLC
Class:
INDUSTRY
Study ID:
P07990
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merck Sharp Dohme LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None